Organogenesis Holdings
ORGO
101 hedge funds and large institutions have $453M invested in Organogenesis Holdings in 2021 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 34 increasing their positions, 18 reducing their positions, and 6 closing their positions.
3,321% more call options, than puts
Call options by funds: $479K | Put options by funds: $14K
583% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 6
182% more capital invested
Capital invested by funds: $161M → $453M (+$292M)
89% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 18
51% more funds holding
Funds holding: 67 → 101 (+34)
2.38% more ownership
Funds ownership: 17.04% → 19.42% (+2.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$40.6M |
| 2 |
BlackRock
New York
|
+$13.9M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$12.2M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
+$12M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$7.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$55M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
-$27.2M |
| 3 |
LCM
Laurion Capital Management
New York
|
-$6.14M |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$6.02M |
| 5 |
Morgan Stanley
New York
|
-$5.15M |
ORGO Hedge Fund Activity: Q1 2021 in Review
101 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q1 2021, worth a combined $453M — up 182% from $161M a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new ORGO positions and 6 closed out — a net gain of 35 holders — while 34 added to existing stakes and 18 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $40.6M. The largest seller was Avidity Partners Management, cutting an estimated $55M.
- 101 institutional investors held Organogenesis Holdings (ORGO) as of Q1 2021, up from 67 in Q4 2020.
- Funds reported $453M of Organogenesis Holdings stock for Q1 2021, up 182% quarter-over-quarter.
- 41 funds opened new Organogenesis Holdings positions in Q1 2021 and 6 closed out, a net change of +35 holders.
- The largest Organogenesis Holdings buyer in Q1 2021 was Deerfield Management, an estimated $40.6M added.
- The largest Organogenesis Holdings seller in Q1 2021 was Avidity Partners Management, an estimated $55M sold.
Based on aggregated 13F filings for Q1 2021.